Home › Funds › GordonMD Global Investments LP › PYXS
GordonMD Global Investments LP position in PYXS
PYXIS ONCOLOGY INC · Health Care
GordonMD Global Investments LP reported holding 15,541,909 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$36.2M, representing 21.75% of its reported portfolio and ranking #1 among its reported holdings. GordonMD Global Investments LP has disclosed PYXS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's PYXS position evolved
GordonMD Global Investments LP first disclosed a stake in PYXS in Q4 2025 at 4,121,870 shares (US$4.7M). The position peaked in Q3 2026 at 15,541,909 shares, worth US$36.2M. Across 4 filings, GordonMD Global Investments LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 15,541,909 shares valued at US$36.2M — an increase of 5,517,000 shares quarter over quarter.. Notable position changes include a 143% increase in Q2 2026 (shares fell 23% over the following quarter), a 55% increase in Q3 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 4.12M | $4.74M | New |
| Q1 2026 | 4.12M | $6.02M | Hold |
| Q2 2026 | 10.02M | $30.17M | Add |
| Q3 2026 | 15.54M | $36.21M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 33 other funds we track also report a position in PYXS — the largest reported positions include PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M), Palo Alto Investors LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Empery Asset Management, LP 1.00M sh · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K sh · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $761.47K · Q3 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held PYXS?
GordonMD Global Investments LP has disclosed PYXS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in PYXS?
As of Q3 2026, GordonMD Global Investments LP holds 15.54M shares of PYXS (PYXIS ONCOLOGY INC), valued at $36.21M, representing 21.75% of its reported portfolio and ranking #1.
Has GordonMD Global Investments LP been buying or selling PYXS?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP increased its position in PYXS. The position peaked in Q3 2026 at 15.54M shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include PFIZER INC, Laurion Capital Management LP, Palo Alto Investors LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.